Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype (2013)
- Authors:
- USP affiliated authors: FORLENZA, ORESTES VICENTE - FM ; GATTAZ, WAGNER FARID - FM
- Unidade: FM
- DOI: 10.6061/CLINICS/2013(02)RC01
- Subjects: POLIMORFISMO; DOENÇA DE ALZHEIMER (GENÉTICA); TESTES NEUROPSICOLÓGICOS; GENES (ANÁLISE); GENÓTIPOS
- Language: Inglês
- Imprenta:
- Source:
- Este artigo possui versão em acesso aberto
- URL de acesso aberto
- Versão do Documento: Versão publicada (Published version)
-
Status: Artigo publicado em periódico de acesso aberto (Gold Open Access) -
ABNT
IZZO, Giselle et al. Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype. Clinics, v. 68, n. 2, p. 277-280, 2013Tradução . . Disponível em: https://doi.org/10.6061/CLINICS/2013(02)RC01. Acesso em: 15 mar. 2026. -
APA
Izzo, G., Forlenza, O. V., Santos, B. dos, Bertolucci, P. H. F., Ojopi, E. B., Gattaz, W. F., & Kerr, D. S. (2013). Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype. Clinics, 68( 2), 277-280. doi:10.6061/CLINICS/2013(02)RC01 -
NLM
Izzo G, Forlenza OV, Santos B dos, Bertolucci PHF, Ojopi EB, Gattaz WF, Kerr DS. Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype [Internet]. Clinics. 2013 ; 68( 2): 277-280.[citado 2026 mar. 15 ] Available from: https://doi.org/10.6061/CLINICS/2013(02)RC01 -
Vancouver
Izzo G, Forlenza OV, Santos B dos, Bertolucci PHF, Ojopi EB, Gattaz WF, Kerr DS. Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype [Internet]. Clinics. 2013 ; 68( 2): 277-280.[citado 2026 mar. 15 ] Available from: https://doi.org/10.6061/CLINICS/2013(02)RC01 - Low Doses of Lithium Changes PKA, AKT and Tau Protein in Cortical and Hippocampal Neurons Cell Culture
- Mild cognitive impairment (part 2): biological markers for diagnosis and prediction of dementia in Alzheimer's disease
- Reduced serum levels of adiponectin in elderly patients with major depression
- Early improvement of psychotic symptoms with lithium monotherapy as a predictor of later response in mania
- Increased platelet GSK3B activity in patients with mild cognitive impairment and Alzheimer's disease
- Diagnosis and biomarkers of predementia in Alzheimer’s disease
- Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study
- Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein
- Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression
- Inhibition of phospolipase A2 modulates glycogen synthase activity and tau phosphorylation in primary cultures of cortical and hippocampal neurons
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
